| Drugs by Condition |  |
Acute Myeloid Leukemia Medications
Drugs associated with Acute Myeloid Leukemia
The following drugs and medications are in some way related to, or used in the treatment of Acute Myeloid Leukemia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
||
|---|---|---|---|---|
Oncovin (More...) generic name: vincristine class: mitotic inhibitors | 0 review(s) | Not rated - Be the first | ||
| Cerubidine (Pro, More...)generic name: daunorubicin class: antibiotics/antineoplastics | 0 review(s) | Not rated - Be the first | ||
| Mylotarg (Pro, More...)generic name: gemtuzumab class: antineoplastic monoclonal antibodies, CD33 monoclonal antibodies, tyrosine kinase inhibitors | 0 review(s) | Not rated - Be the first | ||
| Vincasar PFS (More...)generic name: vincristine class: mitotic inhibitors | 0 review(s) | Not rated - Be the first | ||
| Tarabine PFS (More...)generic name: cytarabine class: antimetabolites | 0 review(s) | Not rated - Be the first | ||
| Cytosar-U (More...)generic name: cytarabine class: antimetabolites | 0 review(s) | Not rated - Be the first | ||
See also...
Acute Myeloid Leukemia Medications in the Pipeline
Zarnestra (tipifarnib)
Ceplene (histamine dihydrochloride)
- February 2, 2009 - EpiCept Receives Permission to File Ceplene NDA
Onrigin (laromustine)
- September 2, 2009 - Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin
- August 12, 2009 - Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin
- April 23, 2009 - Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin
- April 16, 2009 - Vion Pharmaceuticals' New Drug Application for Onrigin Accepted For Review by the FDA
- February 17, 2009 - Vion Pharmaceuticals Submits New Drug Application for Onrigin
Latest Acute Myeloid Leukemia Blog Post
New Drug Could Work Against Leukemia
THURSDAY, July 2 -- A new targeted therapy shows promise in treating acute myeloid leukemia, a highly treatment-resistant blood cancer, according to a new study.
Researchers created an antibody (7G3) that recognizes and binds to a molecule called CD123,...
View all Acute Myeloid Leukemia blog posts.
Acute Myeloid Leukemia Support Group Questions
Go to the Acute Myeloid Leukemia support group or view all Acute Myeloid Leukemia questions.
Ask a Question about Acute Myeloid Leukemia:
Learn more about Acute Myeloid Leukemia
Medical encyclopedia results for:
